InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,290.41
(
0.32%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RockRat

Send PM Follow Ignore
Followers 11
Posts 903
Boards Moderated 0
Alias Born 12/19/2005

RockRat

Re: DewDiligence post# 82019

Friday, 10/15/2010 2:31:23 AM

Friday, October 15, 2010 2:31:23 AM

Post# of 252302
Alchemia (aussie company) and Dr. Reddy's are teaming up to make Arixtra generic (it's been off patent for a few years). They announced today that their plant will be inspected in Novmeber, so maybe next year? Further, Arixtra is now indicated for treatment of DVT. ACS is pending, I gather, dunno the odds there. Obviously, still not an immediate concern, but a bit mores so than it was at the time of this post to which I am replying.

Regards, RockRat
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up